Literature DB >> 30182649

Epidemiology of severe traumatic brain injury.

Corrado Iaccarino1,2, Alessandro Carretta3, Federico Nicolosi4, Carlotta Morselli4.   

Abstract

About 5.48 million people are estimated to suffer from severe traumatic brain injury (TBI) each year (73 cases per 100,000 people). The WHO estimates that almost 90% of deaths due to injuries occur in low- and middle-income countries (LMICs), where the 85% of population live. Of these trauma-related deaths TBI is the main cause of one-third to one-half and represents the greatest cause of death and disability globally among all trauma-related injuries. The primary causes of TBI vary by age, socioeconomic factors, and geographic region, so any planned interventions must take in account this variability. The road traffic injuries (RTI) scenario is still strictly connected to the analysis of the global incidence of TBI, and to the reason why the LMICs experience nearly 3 times as many cases of TBI proportionally than high-income countries (HICs). The proportion of TBIs resulting from road traffic collisions was greatest in Africa and Southeast Asia (both 56%) and lowest in North America (25%). In HICs, falls and RTIs were reported most frequently as cause of TBI, but the traumas attributable to RTIs dropped from 39% in 2003 to 24% in 2012, while those attributable to falls increased from 43% to 54% respectively, with an increase TBI in the elderly (>65 years) due to falls. Differently from HICs, the population with the peak of TBI incidence is younger in LMICs, with an age between 28.8 and 33.1, as extensively reported. The burden of disease is significant; between 1,730,000 and 1,965,000 lives could be saved if global trauma care were improved in LMICs. Clinical practice recommendation should be developed and created in environments where the severe TBI mainly occurs. The applicability of high-income-country clinical research standards in LMICs is an important topic for future international research.

Entities:  

Mesh:

Year:  2018        PMID: 30182649     DOI: 10.23736/S0390-5616.18.04532-0

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  52 in total

Review 1.  A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction.

Authors:  Sule Temizkan; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

2.  Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury.

Authors:  Steven J Schwulst; Mecca B A R Islam
Journal:  J Vis Exp       Date:  2019-08-16       Impact factor: 1.355

3.  Microelectrode implants, inflammatory response and long-lasting effects on NADPH diaphorase neurons in the rat frontal cortex.

Authors:  Joanilson S Guimaraes; Nelson Alessandretti M Lemos; Marco Aurelio M Freire; Antonio Pereira; Sidarta Ribeiro
Journal:  Exp Brain Res       Date:  2022-08-10       Impact factor: 2.064

4.  Licoricidin improves neurological dysfunction after traumatic brain injury in mice via regulating FoxO3/Wnt/β-catenin pathway.

Authors:  Cai Liu; Dongqiang He; Qiming Zhao
Journal:  J Nat Med       Date:  2020-07-12       Impact factor: 2.343

Review 5.  BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.

Authors:  Melissa Pergakis; Neeraj Badjatia; Seemant Chaturvedi; Carolyn A Cronin; W Taylor Kimberly; Kevin N Sheth; J Marc Simard
Journal:  Expert Opin Investig Drugs       Date:  2019-10-24       Impact factor: 6.206

6.  Neurotrauma clinicians' perspectives on the contextual challenges associated with long-term follow-up following traumatic brain injury in low-income and middle-income countries: a qualitative study protocol.

Authors:  Brandon George Smith; Charlotte Jane Whiffin; Ignatius N Esene; Claire Karekezi; Tom Bashford; Muhammad Mukhtar Khan; Davi Jorge Fontoura Solla; Bhagavatula Indira Devi; Peter John Hutchinson; Angelos G Kolias; Anthony Figaji; Andres M Rubiano
Journal:  BMJ Open       Date:  2021-03-04       Impact factor: 2.692

7.  Acute Brain-Derived Neurotrophic Factor DNA Methylation Trajectories in Cerebrospinal Fluid and Associations With Outcomes Following Severe Traumatic Brain Injury in Adults.

Authors:  Amery Treble-Barna; Lacey W Heinsberg; Ava M Puccio; John R Shaffer; David O Okonkwo; Sue R Beers; Daniel E Weeks; Yvette P Conley
Journal:  Neurorehabil Neural Repair       Date:  2021-06-25       Impact factor: 3.919

8.  A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.

Authors:  Jieyu Zhang; Yongkang Zhang; Juntao Zou; Fei Cao
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

9.  Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury.

Authors:  Songzuo Yu; Ka Wu; Yujia Liang; Haitao Zhang; Chao Guo; Bin Yang
Journal:  Aging (Albany NY)       Date:  2021-06-27       Impact factor: 5.682

Review 10.  Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury.

Authors:  Eric E Coris; Byron Moran; Kevin Sneed; Gianluca Del Rossi; Bradford Bindas; Shaan Mehta; Dusty Narducci
Journal:  Sports Health       Date:  2021-07-22       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.